Peer Review reports
From: EGR1 mediates MDR1 transcriptional activity regulating gemcitabine resistance in pancreatic cancer
Original Submission | ||
---|---|---|
11 Nov 2023 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
28 Nov 2023 | Reviewed | Reviewer Report |
7 Dec 2023 | Reviewed | Reviewer Report |
9 Dec 2023 | Reviewed | Reviewer Report |
18 Dec 2023 | Reviewed | Reviewer Report |
1 Jan 2024 | Author responded | Author comments - Shanyu Qin |
Resubmission - Version 3 | ||
1 Jan 2024 | Submitted | Manuscript version 3 |
7 Jan 2024 | Author responded | Author comments - Shanyu Qin |
Resubmission - Version 4 | ||
7 Jan 2024 | Submitted | Manuscript version 4 |
9 Jan 2024 | Reviewed | Reviewer Report |
10 Jan 2024 | Reviewed | Reviewer Report |
11 Jan 2024 | Reviewed | Reviewer Report |
20 Jan 2024 | Reviewed | Reviewer Report |
2 Feb 2024 | Author responded | Author comments - Shanyu Qin |
Resubmission - Version 5 | ||
2 Feb 2024 | Submitted | Manuscript version 5 |
3 Feb 2024 | Author responded | Author comments - Shanyu Qin |
Resubmission - Version 6 | ||
3 Feb 2024 | Submitted | Manuscript version 6 |
3 Feb 2024 | Author responded | Author comments - Shanyu Qin |
Resubmission - Version 7 | ||
3 Feb 2024 | Submitted | Manuscript version 7 |
14 Feb 2024 | Reviewed | Reviewer Report |
Resubmission - Version 8 | ||
Submitted | Manuscript version 8 | |
Publishing | ||
14 Feb 2024 | Editorially accepted | |
26 Feb 2024 | Article published | 10.1186/s12885-024-12005-2 |
You can find further information about peer review here.